{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:26:35Z","timestamp":1792293995228,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010753","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T00:00:00Z","timestamp":1526256000000}}],"reference-count":106,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010753.pub2","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T02:25:35Z","timestamp":1526351135000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Antidepressants for insomnia in adults"],"prefix":"10.1002","volume":"2018","author":[{"given":"Hazel","family":"Everitt","sequence":"first","affiliation":[{"name":"University of Southampton; Primary Care and Population Sciences, Faculty of Medicine; Aldermoor Health Centre Aldermoor Close Southampton UK SO16 5ST"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S","family":"Baldwin","sequence":"additional","affiliation":[{"name":"University of Southampton; University Department of Psychiatry, Faculty of Medicine; Southampton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Stuart","sequence":"additional","affiliation":[{"name":"University of Southampton; Primary Care and Population Sciences, Faculty of Medicine; Aldermoor Health Centre Aldermoor Close Southampton UK SO16 5ST"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gosia","family":"Lipinska","sequence":"additional","affiliation":[{"name":"University of Cape Town; UCT Sleep Sciences, Department of Psychology; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mayers","sequence":"additional","affiliation":[{"name":"Bournemouth University; Department of Psychology, Faculty of Science and Technology; Poole House, Talbot Campus Fern Barrow Poole UK BH12 5BB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L","family":"Malizia","sequence":"additional","affiliation":[{"name":"The Burden Centre, Frenchay hospital; Department of Neurosurgery; Bristol UK BS16 1LE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher CF","family":"Manson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Southampton; University Department of Psychiatry; Academic Centre, College Keep 4-12 Terminus Terrace Southampton UK SO14 3DT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Wilson","sequence":"additional","affiliation":[{"name":"Imperial College London; Centre for Neuropsychopharmacology, Division of Brain Sciences; Burlington Danes Building Hammersmith Hospital campus London UK W12 0NN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,5,14]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD010753.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1017\/S1461145713000679","article-title":"Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24 week randomised, controlled, double blind trial","volume":"16","author":"Corruble","year":"2013","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD010753.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00004714-200204000-00006","article-title":"Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia","volume":"22","author":"Fava","year":"2002","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD010753.pub2-BIB0003|cit3","first-page":"852","article-title":"Doxepin versus imipramine in psychoneurotic depressed patients with sleep disturbance: a double-blind study","volume":"39","author":"Finnerty","year":"1978","journal-title":"Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD010753.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1530-0277.2008.00742.x","article-title":"Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial","volume":"32","author":"Friedmann","year":"2008","journal-title":"Alcoholism Clinical Experimental Research"},{"issue":"5","key":"10.1002\/14651858.CD010753.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4088\/JCP.v58n0502","article-title":"A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial","volume":"58","author":"Gillin","year":"1997","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD010753.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4088\/JCP.v62n0609","article-title":"Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study","volume":"62","author":"Hajak","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.psychres.2013.08.017","article-title":"Insomnia treatment in the third trimester of pregnancy reduces postpartum depression symptoms: a randomised clinical trial","volume":"210","author":"Khazaie","year":"2013","journal-title":"Psychiatry Research"},{"issue":"11","key":"10.1002\/14651858.CD010753.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/sleep\/33.11.1553","article-title":"Efficacy and safety of doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia","volume":"33","author":"Krystal","year":"2010","journal-title":"Sleep"},{"issue":"10","key":"10.1002\/14651858.CD010753.pub2-BIB0009|cit9","first-page":"1433","article-title":"Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia","volume":"34","author":"Krystal","year":"2011","journal-title":"Sleep"},{"issue":"2","key":"10.1002\/14651858.CD010753.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.sleep.2011.09.006","article-title":"Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia","volume":"13","author":"Lankford","year":"2012","journal-title":"Sleep Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010753.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.jcp.0000085411.08426.d3","article-title":"Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations","volume":"23","author":"Bon","year":"2003","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1-2","key":"10.1002\/14651858.CD010753.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000067127","article-title":"Complaints of post-stroke insomnia and its treatment with mianserin","volume":"15","author":"Palomaki","year":"2003","journal-title":"Cerebrovascular Diseases"},{"issue":"9","key":"10.1002\/14651858.CD010753.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/01.JGP.0000218327.21111.de","article-title":"Paroxetine treatment of primary insomnia in older adults","volume":"14","author":"Reynolds","year":"2006","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD010753.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-2002-34119","article-title":"Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study","volume":"35","author":"Riemann","year":"2002","journal-title":"Pharmacopsychiatry"},{"issue":"7","key":"10.1002\/14651858.CD010753.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.parkreldis.2013.03.003","article-title":"Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease: a randomised study","volume":"19","author":"Rios Romenets","year":"2013","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1002\/14651858.CD010753.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2869.2011.00928.x","article-title":"Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacs","volume":"20","author":"Roth","year":"2011","journal-title":"Journal of Sleep Research"},{"issue":"1","key":"10.1002\/14651858.CD010753.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0006-3223(98)00092-4","article-title":"Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder","volume":"44","author":"Rush","year":"1998","journal-title":"Biological Psychology"},{"issue":"2","key":"10.1002\/14651858.CD010753.pub2-BIB0018|cit18","first-page":"227","article-title":"The effects of fluoxetine on symptoms of insomnia in depressed patients","volume":"31","author":"Satterlee","year":"1995","journal-title":"Psychopharmacological Bulletin"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0019|cit19","first-page":"65","article-title":"Sentra PM (a medical food) and trazodone in the management of sleep disorders","volume":"4","author":"Shell","year":"2012","journal-title":"Journal of Central Nervous System Diseases"},{"issue":"1-3","key":"10.1002\/14651858.CD010753.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.drugalcdep.2011.06.026","article-title":"Trazodone for sleep disturbance during methadone maintenance: a double-blind, placebo-controlled trial","volume":"120","author":"Stein","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD010753.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1099-1077(199804)13:3<191::AID-HUP972>3.0.CO;2-X","article-title":"Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia","volume":"13","author":"Walsh","year":"1998","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"issue":"6","key":"10.1002\/14651858.CD010753.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/sleep\/12.6.537","article-title":"Effects on sleep: a double-blind study comparing trimipramine to imipramine in depressed insomniac patients","volume":"12","author":"Ware","year":"1989","journal-title":"Sleep"},{"issue":"3","key":"10.1002\/14651858.CD010753.pub2-BIB0023|cit23","first-page":"185","article-title":"Clinical observation on effects of paroxetine and alprazolam in the treatment of elderly patients with chronic primary insomnia","volume":"21","author":"Zhou","year":"2002","journal-title":"Chinese Journal of Geriatrics"},{"issue":"12","key":"10.1002\/14651858.CD010753.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0028-3908(79)90172-2","article-title":"One gram of L-tryptophan fails to alter the time taken to fall asleep","volume":"18","author":"Adam","year":"1979","journal-title":"Neuropharmacology"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1192\/bjp.155.4.479","article-title":"Clinical assessment and performance tasks in depression: a comparison of amitriptyline and trazodone","volume":"155","author":"Botros","year":"1989","journal-title":"British Journal of Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD010753.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.2337\/dc12-0656","article-title":"Randomised, placebo-controlled comparison of amitriptyline, duloxetine, and pregabaline in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life","volume":"35","author":"Boyle","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/sleep\/zsx019","article-title":"Cognitive behavioral insomnia therapy for those with insomnia and depression: a randomized controlled clinical trial [NCT00620789]","volume":"40","author":"Carney","year":"2017","journal-title":"Sleep"},{"issue":"12","key":"10.1002\/14651858.CD010753.pub2-BIB0028|cit28","first-page":"727","article-title":"Comparison of trazodone and paroxetine in treating dyssomnia of anxiety disorder","volume":"21","author":"Chen","year":"2002","journal-title":"Chinese Journal of New Drugs and Clinical Remedies"},{"issue":"S2","key":"10.1002\/14651858.CD010753.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0924-977X(97)88491-X","article-title":"Fluoxetine and dothiepin in depressed patients: a comparison of efficacy and effects on cognition and subjective sleep","volume":"7","author":"Fairweather","year":"1997","journal-title":"European Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD010753.pub2-BIB0030|cit30","first-page":"35","article-title":"Tryptophan in the treatment of insomnia in hospitalised psychiatric patients","volume":"13","author":"Ferrero","year":"1987","journal-title":"Encephale"},{"issue":"5","key":"10.1002\/14651858.CD010753.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-2007-979569","article-title":"Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia","volume":"29","author":"Hajak","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0032|cit32","first-page":"S528","article-title":"Comparison of sleep outcomes in generalized anxiety disorder following treatment with pregabalin or venlafaxine-XR","volume":"24 (Suppl 1)","author":"Herman","year":"2009","journal-title":"European Psychiatry"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0033|cit33","first-page":"S534","article-title":"Insomnia and quality of life in generalized anxiety disorder: impact on clinical presentation and response to pregabalin and venlafaxine-XR","volume":"24 (Suppl 1)","author":"Mychaskiw","year":"2009","journal-title":"European Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD010753.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/0269881116681399","article-title":"Low doses of mirtazapine or quetiapine for transient insomnia: a randomised, double-blind, cross-over, placebo-controlled trial","volume":"31","author":"Karsten","year":"2017","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD010753.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.sleep.2003.06.006","article-title":"The effects of trazodone on sleep in patients treated with stimulant antidepressants","volume":"5","author":"Kaynak","year":"2004","journal-title":"Sleep Medicine"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0036|cit36","first-page":"21","article-title":"A double-blind study of the effects of Dothiepin (75\/150 mg nocte) on sleep and morning psychomotor function","volume":"2","author":"Moon","year":"1991","journal-title":"British Journal of Clinical Research"},{"issue":"9","key":"10.1002\/14651858.CD010753.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.sleep.2012.06.001","article-title":"Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program","volume":"13","author":"Palesh","year":"2012","journal-title":"Sleep Medicine"},{"issue":"11","key":"10.1002\/14651858.CD010753.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/sleep\/30.11.1555","article-title":"Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia","volume":"30","author":"Roth","year":"2007","journal-title":"Sleep"},{"issue":"5","key":"10.1002\/14651858.CD010753.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/JCP.0000000000000546","article-title":"A phase 2 randomized dose-finding study with esmirtazapine in patients with primary insomnia","volume":"36","author":"Ruwe","year":"2016","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD010753.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4088\/JCP.v69n1005","article-title":"Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study","volume":"69","author":"Scharf","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD010753.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s12325-011-0071-8","article-title":"Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder","volume":"28","author":"Stein","year":"2011","journal-title":"Advances in Therapy"},{"issue":"7","key":"10.1002\/14651858.CD010753.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/1099-1077(200010)15:7<529::AID-HUP232>3.0.CO;2-G","article-title":"The impact of antidepressants on sleep and anxiety: a comparative study of fluoxetine and dothiepin using the Leeds Sleep Evaluation Questionnaire","volume":"15","author":"Stephenson","year":"2000","journal-title":"Human Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD010753.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5664\/jcsm.5400","article-title":"The effects of milnacipran on sleep disturbance in fibromyalgia: a randomized, double-blind, placebo-controlled, two-way crossover study","volume":"12","author":"Ahmed","year":"2016","journal-title":"Journal of Clinical Sleep Medicine"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.sleep.2015.04.001","article-title":"Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial","volume":"16","author":"Ivgy-May","year":"2015","journal-title":"Sleep Medicine"},{"issue":"7","key":"10.1002\/14651858.CD010753.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.sleep.2015.03.005","article-title":"Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial","volume":"16","author":"Ivgy-May","year":"2015","journal-title":"Sleep Medicine"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0046|cit46","first-page":"A222","article-title":"Efficacy and safety of esmirtazapine in elderly patients with primary insomnia in a 2-week sleep laboratory trial","volume":"35","author":"Krystal","year":"2012","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0047|cit47","unstructured":"Merck Sharp Dohme Corp A 6-month efficacy and safety study of org 50081 in adult patients with chronic primary insomnia (21106\/P05701\/MK-8265-002) ClinicalTrials.gov\/show\/NCT00631657"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-9338(12)75521-9","article-title":"Comparative effects of venlafaxine and mirtazepine on sleep physiology measures in patients with major depressive disorder and insomnia","volume":"27 (Suppl 1)","author":"Miljatovic","year":"2012","journal-title":"European Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD010753.pub2-BIB0049|cit49","first-page":"562","article-title":"Comparison of melissa with citalopram and placebo in treatment of sleep disorders in menopausal women: clinical trial","volume":"74","author":"Shirazi","year":"2016","journal-title":"Tehran University Medical Journal"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3892\/etm.2015.2686","article-title":"Efficacy and safety evaluation of citalopram and doxepin on sleep quality in comorbid insomnia and anxiety disorders","volume":"10","author":"Wu","year":"2015","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0051|cit51","unstructured":"ChiCTR-IPR-16009475 Shanghai Mental Health Center The research of chronic insomnia clinical evaluation and optimization of treatment www.chictr.org.cn\/showproj.aspx?proj=16136"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0052|cit52","first-page":"A127","article-title":"Sequenced therapies for comorbid and primary insomnia: preliminary findings of a randomized controlled trial","volume":"40 (Suppl 1)","author":"Morin","year":"2015","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0053|cit53","unstructured":"NCT02139098 Alternative dosing regimens in the pharmacotherapy of insomnia (ALPHASOM) clinicaltrials.gov\/ct2\/show\/NCT02139098"},{"issue":"3","key":"10.1002\/14651858.CD010753.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2869.2008.00671.x","article-title":"Sleep loss affects vigilance: effects of chronic insomnia and sleep therapy","volume":"17","author":"Altena","year":"2008","journal-title":"Journal of Sleep Research"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.smrv.2016.06.005","article-title":"Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders","volume":"34","author":"Auld","year":"2017","journal-title":"Sleep Med Rev."},{"issue":"4","key":"10.1002\/14651858.CD010753.pub2-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006814","article-title":"Cognitive behavioural therapy for insomnia","author":"Aversa Lopes","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2011.01.011","article-title":"Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies","volume":"135","author":"Baglioni","year":"2011","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0058|cit58","first-page":"34","article-title":"New epidemiologic findings about insomnia and its treatment","volume":"53 Suppl","author":"Balter","year":"1992","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD010753.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0006-3223(95)00188-3","article-title":"Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults","volume":"39","author":"Breslau","year":"1996","journal-title":"Biological Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD010753.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s11606-007-0251-z","article-title":"The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs","volume":"22","author":"Buscemi","year":"2007","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Research"},{"issue":"9","key":"10.1002\/14651858.CD010753.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005472.pub3","article-title":"Acupuncture for insomnia","author":"Cheuk","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD010753.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/026988119901304S04","article-title":"Evaluation of severe insomnia in the general population: results of a European multinational survey","volume":"13","author":"Chevalier","year":"1999","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0064|cit64","first-page":"1","article-title":"Benzodiazepines, dependence and withdrawal symptoms","volume":"21","author":"Committee on Safety of Medicines","year":"1988","journal-title":"Medicines Control Agency"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0065|cit65","unstructured":"American Psychiatric Association Insomnia disorder Diagnostic and Statistical Manual of Mental Disorders, 5th edition 2015"},{"issue":"5","key":"10.1002\/14651858.CD010753.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/sleep\/31.5.599","article-title":"Psychomotor performance deficits and their relation to prior nights' sleep among individuals with primary insomnia","volume":"31","author":"Edinger","year":"2008","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3399\/bjgp14X677176","article-title":"General practitioners' management strategies for patients with insomnia: a survey and qualitative interview study","volume":"64","author":"Everitt","year":"2014","journal-title":"British Journal of General Practice"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0069|cit69","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4","key":"10.1002\/14651858.CD010753.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1440-1819.1999.00578.x","article-title":"Epidemiological study on sleep habits and insomnia of new outpatients visiting general hospitals in Japan","volume":"53","author":"Ishigooka","year":"1999","journal-title":"Psychiatry and Clinical Neurosciences"},{"issue":"7","key":"10.1002\/14651858.CD010753.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/sleep\/26.7.793","article-title":"Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia","volume":"26","author":"Krystal","year":"2003","journal-title":"Sleep"},{"issue":"1","key":"10.1002\/14651858.CD010753.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/sleep\/31.1.79","article-title":"Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study","volume":"31","author":"Krystal","year":"2008","journal-title":"Sleep"},{"issue":"4","key":"10.1002\/14651858.CD010753.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.smrv.2008.08.001","article-title":"A compendium of placebo-controlled trials of the risks\/benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice","volume":"13","author":"Krystal","year":"2009","journal-title":"Sleep Medicine Reviews"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/DHPS.S21079","article-title":"Prevalence and factors associated with off-label antidepressant prescriptions for insomnia","volume":"3","author":"Lai","year":"2011","journal-title":"Drug, Healthcare and Patient Safety"},{"issue":"8","key":"10.1002\/14651858.CD010753.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/sleep\/32.8.1027","article-title":"Incidence and risk factors of insomnia in a population-based sample","volume":"32","author":"LeBlanc","year":"2009","journal-title":"Sleep"},{"issue":"1","key":"10.1002\/14651858.CD010753.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00006842-200101000-00006","article-title":"SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers","volume":"63","author":"Leger","year":"2001","journal-title":"Psychosomatic Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010753.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2869.2007.00613.x","article-title":"Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects","volume":"16","author":"Lemoine","year":"2007","journal-title":"Journal of Sleep Research"},{"issue":"3","key":"10.1002\/14651858.CD010753.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5665\/sleep\/32.3.351","article-title":"Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia","volume":"32","author":"Mayer","year":"2009","journal-title":"Sleep"},{"issue":"8","key":"10.1002\/14651858.CD010753.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/hup.726","article-title":"Antidepressants and their effect on sleep","volume":"20","author":"Mayers","year":"2005","journal-title":"Human Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD010753.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archpsyc.1985.01790260019002","article-title":"Insomnia and its treatment. Prevalence and correlates","volume":"42","author":"Mellinger","year":"1985","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD010753.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"11","key":"10.1002\/14651858.CD010753.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jama.281.11.991","article-title":"Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial","volume":"281","author":"Morin","year":"1999","journal-title":"Journal of the American Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD010753.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.PSY.0000030391.09558.A3","article-title":"Role of stress, arousal, and coping skills in primary insomnia","volume":"65","author":"Morin","year":"2003","journal-title":"Psychosomatic Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010753.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/sleep\/34.5.601","article-title":"The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response","volume":"34","author":"Morin","year":"2011","journal-title":"Sleep"},{"issue":"7","key":"10.1002\/14651858.CD010753.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.clinthera.2006.07.008","article-title":"Patient characteristics and patterns of drug use for sleep complaints in the United States: analysis of national ambulatory medical survey data, 1997-2002","volume":"28","author":"Morlock","year":"2006","journal-title":"Clinical Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD010753.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/sleep\/30.7.873","article-title":"Chronic insomnia as a risk factor for developing anxiety and depression","volume":"30","author":"Neckelmann","year":"2007","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0087|cit87","unstructured":"NHS Digital Prescription Cost Analysis England 2010 digital.nhs.uk\/data-and-information\/publications\/statistical\/prescription-cost-analysis\/prescription-cost-analysis-england-2010"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0088|cit88","unstructured":"National Institute for Clinical Excellence (NICE) Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia (Technology Appraisal 77) www.nice.org.uk\/guidance\/ta77 (accessed 12 September 2013) 2004"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0089|cit89","unstructured":"National institute of Health Consensus Development Programme Drugs and insomnia: the use of medications to promote sleep consensus.nih.gov\/1983\/1983insomniadrugs039html.htm 1983"},{"issue":"9","key":"10.1002\/14651858.CD010753.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/sleep\/28.9.1049","article-title":"National Institutes of Health State of the Science conference statement on manifestations and management of chronic insomnia in adults","volume":"28","author":"NIH","year":"2005","journal-title":"Sleep"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD010753.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2869.2010.00872.x","article-title":"Sleep-related memory consolidation in primary insomnia","volume":"20","author":"Nissen","year":"2011","journal-title":"Journal of Sleep Research"},{"issue":"4","key":"10.1002\/14651858.CD010753.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0022-3999(98)00079-8","article-title":"Are prescribed medications effective in the treatment of insomnia complaints?","volume":"47","author":"Ohayon","year":"1999","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0093|cit93","first-page":"850","article-title":"Chapter 78: models of insomnia","volume-title":"Principles and Practice of Sleep Medicine","author":"Perlis","year":"2010"},{"issue":"7","key":"10.1002\/14651858.CD010753.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.sleep.2006.04.006","article-title":"Insomniac complaints interfere with quality of life but not with absenteeism: respective role of depressive and organic comorbidity","volume":"7","author":"Philip","year":"2006","journal-title":"Sleep Medicine"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0095|cit95","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.smrv.2008.06.001","article-title":"The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioural therapies","volume":"13","author":"Riemann","year":"2009","journal-title":"Sleep Medicine Reviews"},{"issue":"12","key":"10.1002\/14651858.CD010753.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/jnnp.2008.144964","article-title":"Antidepressants for neuropathic pain: a Cochrane review","volume":"81","author":"Saarto","year":"2010","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"9449","key":"10.1002\/14651858.CD010753.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(04)17480-1","article-title":"Insomnia","volume":"364","author":"Sateia","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD010753.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/15402000903190199","article-title":"Insomnia symptoms and use of health care services and medications: the HUNT-2 study","volume":"7","author":"Sivertsen","year":"2009","journal-title":"Behavioral Sleep Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010753.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/da.21951","article-title":"Comparative effectiveness of second-generation antidepressants for accompanying anxiety insomnia and pain in depressed patients: a systematic review","volume":"29","author":"Thaler","year":"2012","journal-title":"Depression and Anxiety"},{"issue":"4","key":"10.1002\/14651858.CD010753.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/sleep\/32.4.491","article-title":"Insomnia with objective short sleep duration is associated with a high risk for hypertension","volume":"32","author":"Vgontzas","year":"2009","journal-title":"Sleep"},{"issue":"10","key":"10.1002\/14651858.CD010753.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1185\/030079907X233098","article-title":"Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes","volume":"23","author":"Wade","year":"2007","journal-title":"Current Medical Research and Opinion"},{"issue":"8","key":"10.1002\/14651858.CD010753.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/sleep\/30.8.959","article-title":"Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations","volume":"30","author":"Walsh","year":"2007","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD010753.pub2-BIB0104|cit104","volume-title":"ICD-10 Classifications of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines","author":"World Health Organization","year":"1992"},{"issue":"7","key":"10.1002\/14651858.CD010753.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2165\/00003495-200565070-00003","article-title":"Antidepressants and sleep: a qualitative review of the literature","volume":"65","author":"Wilson","year":"2005","journal-title":"Drugs"},{"issue":"11","key":"10.1002\/14651858.CD010753.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1177\/0269881110379307","article-title":"British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders","volume":"24","author":"Wilson","year":"2010","journal-title":"Journal of Psychopharmacology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010753.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T12:35:58Z","timestamp":1626611758000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010753.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,14]]},"references-count":106,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010753.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,14]]}}}